Moorpark, CA, United States of America

Anne Y Saiki

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Anne Y Saiki

Introduction

Anne Y Saiki is a prominent inventor based in Moorpark, California. She has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With a total of four patents to her name, her work focuses on innovative therapies that aim to improve patient outcomes.

Latest Patents

One of her latest patents involves a combination therapy that includes a KRAS inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers. This invention provides a novel approach to cancer treatment by utilizing a KRAS inhibitor, which can be a pharmaceutically acceptable salt, in conjunction with other active agents. The patent also encompasses pharmaceutical compositions that contain these components, further enhancing the therapeutic options available for cancer patients.

Career Highlights

Anne Y Saiki is currently associated with Amgen Inc., a leading biotechnology company. Her work at Amgen has allowed her to collaborate with some of the brightest minds in the industry, contributing to groundbreaking advancements in medical science.

Collaborations

Some of her notable coworkers include Jude Robert Canon and James Russell Lipford. Their collective expertise has fostered an environment of innovation and collaboration, driving forward the development of effective cancer therapies.

Conclusion

Anne Y Saiki's contributions to the field of pharmaceuticals, particularly in cancer treatment, highlight her role as a leading inventor. Her innovative approaches and collaborations continue to pave the way for advancements in medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…